Advancements in targeted and immunotherapy strategies for glioma: toward precision treatment
In recent years, significant breakthroughs have been made in cancer therapy, particularly with the development of molecular targeted therapies and immunotherapies, owing to advances in tumor molecular biology and molecular immunology. High-grade gliomas (HGGs), characterized by their high malignancy...
Saved in:
Main Authors: | Guangyuan Gong, Lang Jiang, Jing Zhou, Yuanchao Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1537013/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current concept on pediatric low-grade glioma in the era of molecular diagnosis
by: Tzu-Chiang Peng, et al.
Published: (2024-12-01) -
Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
by: Yonghua Cai, et al.
Published: (2025-02-01) -
RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
by: Wei Wei, et al.
Published: (2025-01-01) -
Differentiation therapy targeting the stalled epigenetic developmental programs in pediatric high-grade gliomas
by: Wang Xiang, et al.
Published: (2025-02-01) -
Cinnamaldehyde impacts key cellular signaling pathways for induction of programmed cell death in high-grade and low-grade human glioma cells
by: Yoo Na Kim, et al.
Published: (2025-01-01)